Axonics Modulation Technologies Inc diskutieren
Axonics Modulation Technologies Inc
WKN: A2N7B2 / Symbol: AXNX / Name: Axonics Modulation Technologies / Aktie / Ausrüstung & Versorgung / Small Cap /
59,00 €
-
Axonics, Inc. (NASDAQ: AXNX) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) is now covered by analysts at CL King. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its "buy" rating re-affirmed by analysts at Mizuho. They now have a $75.00 price target on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target raised by analysts at Needham & Company LLC from $73.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) is now covered by analysts at SVB Leerink LLC. They set an "outperform" rating and a $70.00 price target on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target lowered by analysts at Morgan Stanley from $76.00 to $69.00. They now have an "overweight" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target lowered by analysts at Needham & Company LLC from $76.00 to $63.00. They now have a "buy" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target lowered by analysts at Piper Sandler from $84.00 to $75.00. They now have an "overweight" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Axonics, Inc. (NASDAQ: AXNX) had its price target raised by analysts at Truist Financial Co. from $65.00 to $73.00. They now have a "buy" rating on the stock.
Ratings data for AXNX provided by MarketBeat
Neueste Beiträge
HC_Wainwright in Sangamo Bioscienes diskutieren, Sangamo Therapeutics Inc.